ABSTRACT
BACKGROUND: Nutcracker syndrome (NCS) is characterized by compression of the left renal vein (LRV) between the aorta and the superior mesenteric artery. While rare, NCS was reported to be accompanied by double inferior vena cava (IVC). We herein report a case of Noonan syndrome (NS) with double IVC who presented with macrohematuria and proteinuria. CASE PRESENTATION: The patient was a 23-year-old man, who had been diagnosed with NS due to RIT1 mutation, after showing foamy macrohematuria 3 weeks previously. A physical examination revealed low-set ears and a webbed neck. A urinalysis showed hematuria and proteinuria, and urinary sediments showed more than 100 isomorphic red blood cells per high-power field. His proteinuria and albuminuria concentrations were 7.1 and 4.5 g/gâ Cr, respectively. Three-dimensional contrast-enhanced computed tomography (CT) showed double IVC and narrowing of the LRV after interflow of the left IVC. The aortomesenteric angle on a sagittal reconstruction of the CT image was 14.7°. Cystoscopy revealed a flow of macrohematuria from the left ureteral opening. On Doppler ultrasonography, there was scant evidence to raise the suspicion of the nutcracker phenomenon. Since severe albuminuria continued, a left kidney biopsy was performed. Light microscopy showed red blood cells in Bowman's space and the tubular lumen. Electron microscopy revealed disruption of the glomerular basement membrane (GBM). Vulnerability of the GBM was suspected and a genetic analysis revealed a heterozygous mutation at c.4793 T > G (p.L1598R) in the COL4A3 gene. Screening for coagulation disorders revealed the factor VIII and von Willebrand factor (vWF) values were low, at 47.6 and 23%, respectively. A multimer analysis of vWF showed a normal multimer pattern and he was diagnosed with von Willebrand disease type 1. As the bleeding tendency was mild, replacement of factor VIII was not performed. His macrohematuria and proteinuria improved gradually without treatment, and his urinalysis results have been normal for more than 6 months. CONCLUSIONS: The present case showed macrohematuria and proteinuria due to NCS in NS with double IVC and von Willebrand disease type 1. The macrohematuria and proteinuria originated from glomerular hemorrhage because of vulnerability of the GBM due to COL4A3 mutation.
Subject(s)
Hematuria/etiology , Noonan Syndrome/complications , Proteinuria/etiology , Renal Nutcracker Syndrome/complications , Vena Cava, Inferior/abnormalities , Autoantigens/genetics , Collagen Type IV/genetics , Glomerular Basement Membrane/physiopathology , Hematuria/genetics , Hematuria/physiopathology , Humans , Male , Mutation , Proteinuria/genetics , Proteinuria/physiopathology , Young Adult , von Willebrand Disease, Type 1/complications , von Willebrand Disease, Type 1/diagnosisABSTRACT
BACKGROUND: Autoantibodies binding to podocyte antigens cause idiopathic membranous glomerulonephritis (iMGN). However, it remains elusive how autoantibodies reach the subepithelial space because the glomerular filtration barrier (GFB) is size selective and almost impermeable for antibodies. METHODS: Kidney biopsies from patients with iMGN, cell culture, zebrafish, and mouse models were used to investigate the role of nephronectin (NPNT) regulating microRNAs (miRs) for the GFB. RESULTS: Glomerular endothelial cell (GEC)-derived miR-192-5p and podocyte-derived miR-378a-3p are upregulated in urine and glomeruli of patients with iMGN, whereas glomerular NPNT is reduced. Overexpression of miR-192-5p and morpholino-mediated npnt knockdown induced edema, proteinuria, and podocyte effacement similar to podocyte-derived miR-378a-3p in zebrafish. Structural changes of the glomerular basement membrane (GBM) with increased lucidity, splitting, and lamellation, especially of the lamina rara interna, similar to ultrastructural findings seen in advanced stages of iMGN, were found. IgG-size nanoparticles accumulated in lucidity areas of the lamina rara interna and lamina densa of the GBM in npnt-knockdown zebrafish models. Loss of slit diaphragm proteins and severe structural impairment of the GBM were further confirmed in podocyte-specific Npnt knockout mice. GECs downregulate podocyte NPNT by transfer of miR-192-5p-containing exosomes in a paracrine manner. CONCLUSIONS: Podocyte NPNT is important for proper glomerular filter function and GBM structure and is regulated by GEC-derived miR-192-5p and podocyte-derived miR-378a-3p. We hypothesize that loss of NPNT in the GBM is an important part of the initial pathophysiology of iMGN and enables autoantigenicity of podocyte antigens and subepithelial immune complex deposition in iMGN.
Subject(s)
Endothelial Cells/metabolism , Extracellular Matrix Proteins/biosynthesis , Glomerular Basement Membrane/metabolism , Glomerular Basement Membrane/physiopathology , Glomerulonephritis, Membranous/genetics , Kidney Glomerulus/metabolism , MicroRNAs/physiology , Animals , Antigen-Antibody Complex/analysis , Autoantigens/genetics , Autoantigens/immunology , Cells, Cultured , Coculture Techniques , Exosomes/metabolism , Extracellular Matrix Proteins/deficiency , Extracellular Matrix Proteins/physiology , Gene Expression Regulation , Gene Targeting , Glomerular Basement Membrane/immunology , Glomerular Basement Membrane/ultrastructure , Glomerulonephritis, Membranous/immunology , Glomerulonephritis, Membranous/metabolism , Glomerulonephritis, Membranous/physiopathology , Gold Sodium Thiosulfate , Humans , Metal Nanoparticles , Mice , MicroRNAs/biosynthesis , MicroRNAs/genetics , MicroRNAs/urine , Paracrine Communication , Permeability , Podocytes/immunology , Podocytes/metabolism , Proteinuria/etiology , Transfection , Zebrafish , Zebrafish Proteins/deficiency , Zebrafish Proteins/geneticsSubject(s)
Albuminuria/physiopathology , Kidney Glomerulus/blood supply , Podocytes/physiology , Renal Insufficiency, Chronic/physiopathology , Autoimmunity , Glomerular Basement Membrane/physiopathology , Glomerular Filtration Rate , Humans , Kidney Glomerulus/physiopathology , Podocytes/immunology , Podocytes/pathologyABSTRACT
The glomerular basement membrane (GBM) is a key component of the glomerular capillary wall and is essential for kidney filtration. The major components of the GBM include laminins, type IV collagen, nidogens and heparan sulfate proteoglycans. In addition, the GBM harbours a number of other structural and regulatory components and provides a reservoir for growth factors. New technologies have improved our ability to study the composition and assembly of basement membranes. We now know that the GBM is a complex macromolecular structure that undergoes key transitions during glomerular development. Defects in GBM components are associated with a range of hereditary human diseases such as Alport syndrome, which is caused by defects in the genes COL4A3, COL4A4 and COL4A5, and Pierson syndrome, which is caused by variants in LAMB2. In addition, the GBM is affected by acquired autoimmune disorders and metabolic diseases such as diabetes mellitus. Current treatments for diseases associated with GBM involvement aim to reduce intraglomerular pressure and to treat the underlying cause where possible. As our understanding about the maintenance and turnover of the GBM improves, therapies to replace GBM components or to stimulate GBM repair could translate into new therapies for patients with GBM-associated disease.
Subject(s)
Anti-Glomerular Basement Membrane Disease/etiology , Diabetic Nephropathies/etiology , Glomerular Basement Membrane/pathology , Glomerular Basement Membrane/physiopathology , Myasthenic Syndromes, Congenital/etiology , Nephritis, Hereditary/etiology , Nephrotic Syndrome/etiology , Pupil Disorders/etiology , HumansABSTRACT
Proteinuria encompasses diverse causes including both genetic diseases and acquired forms such as diabetic and hypertensive nephropathy. The basis of proteinuria is a disturbance in size selectivity of the glomerular filtration barrier, which largely depends on the podocyte: a terminally differentiated epithelial cell type covering the outer surface of the glomerulus. Compromised podocyte structure is one of the earliest signs of glomerular injury. The phenotype of diverse animal models and podocyte cell culture firmly established the essential role of the actin cytoskeleton in maintaining functional podocyte structure. Podocyte foot processes, actin-based membrane extensions, contain 2 molecularly distinct "hubs" that control actin dynamics: a slit diaphragm and focal adhesions. Although loss of foot processes encompasses disassembly of slit diaphragm multiprotein complexes, as long as cells are attached to the glomerular basement membrane, focal adhesions will be the sites in which stress due to filtration flow is counteracted by forces generated by the actin network in foot processes. Numerous studies within last 20 years have identified actin binding and regulatory proteins as well as integrins as essential components of signaling and actin dynamics at focal adhesions in podocytes, suggesting that some of them may become novel, druggable targets for proteinuric kidney diseases. Here we review evidence supporting the idea that current treatments for chronic kidney diseases beneficially and directly target the podocyte actin cytoskeleton associated with focal adhesions and suggest that therapeutic reagents that target the focal adhesion-regulated actin cytoskeleton in foot processes have potential to modernize treatments for chronic kidney diseases.
Subject(s)
Actin Cytoskeleton/metabolism , Actins/metabolism , Focal Adhesions/metabolism , Glomerular Basement Membrane/metabolism , Podocytes/metabolism , Proteinuria/metabolism , Renal Insufficiency, Chronic/metabolism , Actin Cytoskeleton/drug effects , Actin Cytoskeleton/pathology , Animals , Focal Adhesions/drug effects , Focal Adhesions/pathology , Glomerular Basement Membrane/drug effects , Glomerular Basement Membrane/pathology , Glomerular Basement Membrane/physiopathology , Glomerular Filtration Rate , Humans , Molecular Targeted Therapy , Podocytes/drug effects , Podocytes/pathology , Proteinuria/drug therapy , Proteinuria/genetics , Proteinuria/pathology , Renal Agents/therapeutic use , Renal Insufficiency, Chronic/drug therapy , Renal Insufficiency, Chronic/genetics , Renal Insufficiency, Chronic/pathology , Signal TransductionABSTRACT
Renal prognosis for anti-glomerular basement membrane (GBM) glomerulonephritis is poor. The greater the amount of anti-GBM antibody binding the antigen (type IV collagen of the glomerular basement membrane), the greater the number of crescents that develop in glomeruli, resulting in progression of renal impairment. Immunofluorescence staining reveals linear IgG depositions on glomerular capillary walls. Membranous nephropathy (MN) is one of the most common causes of nephrotic syndrome in middle-aged to elderly patients. Immune complex is deposited in the sub-epithelial space of the glomerulus resulting in the development of a membranous lesion. Immunofluorescence staining reveals granular IgG depositions on glomerular capillary walls. Coexisting anti-GBM glomerulonephritis and MN are rare and, here we report a case of coexisting anti-GBM glomerulonephritis and MN with preserved renal function. There are some cases of coexisting anti-GBM glomerulonephritis and MN do not show severely decreased renal function. A 76-year-old Japanese woman presented with nephrotic syndrome, microscopic hematuria, and was positive for anti-GBM antibody. Kidney biopsy revealed linear and granular IgG depositions in glomerular capillary walls, crescent formations, and electron-dense deposits in the sub-epithelial space. She was diagnosed with anti-GBM glomerulonephritis and MN. Steroid and cyclosporine therapy achieved complete remission, and kidney function was preserved. In conclusion, coexisting anti-GBM glomerulonephritis and MN can have preserved renal function. IgG subclass of deposited anti-GBM antibody may be associated with the severity of anti-GBM glomerulonephritis. In addition, in the case of nephrotic syndrome with hematuria, we should consider the possibility of coexisting anti-GBM glomerulonephritis and MN.
Subject(s)
Autoantibodies/immunology , Glomerular Basement Membrane/pathology , Glomerular Basement Membrane/physiopathology , Glomerulonephritis, Membranous/complications , Glomerulonephritis, Membranous/physiopathology , Kidney Function Tests , Aged , Biopsy , Female , Humans , Kidney/pathologyABSTRACT
Neuropilin1 (Nrp1) is a co-receptor best known to regulate the development of endothelial cells and is a target of anticancer therapies. However, its role in other vascular cells including pericytes is emergent. The kidney is an organ with high pericyte density and cancer patients develop severe proteinuria following administration of NRP1B-neutralizing antibody combined with bevacizumab. Therefore, we investigated whether Nrp1 regulates glomerular capillary integrity after completion of renal development using two mouse models; tamoxifen-inducible NG2Cre to delete Nrp1 specifically in pericytes and administration of Nrp1-neutralizing antibodies. Specific Nrp1 deletion in pericytes did not affect pericyte number but mutant mice developed hematuria with glomerular basement membrane defects. Despite foot process effacement, albuminuria was absent and expression of podocyte proteins remained unchanged upon Nrp1 deletion. Additionally, these mice displayed dilation of the afferent arteriole and glomerular capillaries leading to glomerular hyperfiltration. Nidogen-1 mRNA was downregulated and collagen4α3 mRNA was upregulated with no significant effect on the expression of other basement membrane genes in the mutant mice. These features were phenocopied by treating wild-type mice with Nrp1-neutralizing antibodies. Thus, our results reveal a postdevelopmental role of Nrp1 in renal pericytes as an important regulator of glomerular basement membrane integrity. Furthermore, our study offers novel mechanistic insights into renal side effects of Nrp1 targeting cancer therapies.
Subject(s)
Glomerular Basement Membrane/metabolism , Glomerular Filtration Rate , Kidney Glomerulus/metabolism , Neuropilin-1/metabolism , Pericytes/metabolism , Albuminuria/genetics , Albuminuria/metabolism , Albuminuria/physiopathology , Animals , Antibodies, Neutralizing/pharmacology , Arterioles/metabolism , Arterioles/physiopathology , Autoantigens/genetics , Autoantigens/metabolism , Capillaries/metabolism , Capillaries/physiopathology , Collagen Type IV/genetics , Collagen Type IV/metabolism , Gene Expression Regulation , Genotype , Glomerular Basement Membrane/drug effects , Glomerular Basement Membrane/physiopathology , Glomerular Basement Membrane/ultrastructure , Hematuria/genetics , Hematuria/metabolism , Hematuria/physiopathology , Kidney Glomerulus/blood supply , Kidney Glomerulus/drug effects , Kidney Glomerulus/physiopathology , Male , Membrane Glycoproteins/genetics , Membrane Glycoproteins/metabolism , Mice, Inbred C57BL , Mice, Knockout , Neuropilin-1/antagonists & inhibitors , Neuropilin-1/deficiency , Neuropilin-1/genetics , Pericytes/drug effects , Pericytes/ultrastructure , Phenotype , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction , VasodilationABSTRACT
Obstructive nephropathy ultimately leads to end-stage renal failure. Renovascular lesions are involved in various nephropathies, and most renal diseases have an ischemic component that underlies the resulting renal fibrosis. The aim of this study was to investigate whether morphological changes occur in the renal vasculature in hydronephrosis and the possible mechanisms involved. A model of complete unilateral ureteral obstruction (CUUO) was used. Experimental animals were divided into five groups: a normal control group (N) and groups of animals at 1st week (O1), 2nd week (O2), 4th week (O4) and 8th week (O8) after CUUO. Blood pressure was measured, renal arterial trees and glomeruli were assessed quantitatively, and renovascular three-dimensional reconstruction was performed on all groups. Glomerular ultrastructural changes were examined by transmission electron microscopy. The results showed that the systolic blood pressure was significantly increased in the obstructed groups (O1, O2, O4 and O8). Three-dimensional reconstruction showed sparse arterial trees in the O8 group, and a tortuous and sometimes ruptured glomerular basement membrane was found in the O4 and O8 groups. Furthermore, epithelial media thickness and media/lumen ratio were increased, lumen diameters were decreased, and the cross-sectional area of the media was unaltered in the segmental renal artery, interlobar artery and afferent arterioles, respectively. In conclusion, renal arterial trees and glomeruli were dramatically altered following CUUO and the changes may be partially ascribed to vascular remodeling. Elucidation of the molecular mechanisms of renovascular morphological alterations will enable the development of potential therapeutic approaches for hydronephrosis.
Subject(s)
Blood Pressure , Glomerular Basement Membrane , Hydronephrosis , Animals , Disease Models, Animal , Glomerular Basement Membrane/blood supply , Glomerular Basement Membrane/pathology , Glomerular Basement Membrane/physiopathology , Hydronephrosis/pathology , Hydronephrosis/physiopathology , Male , Rabbits , Renal Artery/pathology , Renal Artery/physiopathologyABSTRACT
Glomerular endothelial surface layer (ESL) may play a role in the mechanisms of albuminuria in diabetic nephropathy, which lack evidence in vivo. The effects of high glucose on the passage of albumin across the glomerular ESL were analysed in streptozotocin-induced diabetic Sprague-Dawley rats for 4 weeks. Albuminuria and glomerular mesangial matrix were significantly increased in diabetic rats. The passage of albumin across the ESL, as measured by albumin-colloid gold particle density in the glomerular basement membrane (GBM), was increased significantly in diabetic rats. The thickness of the glomerular ESL, examined indirectly by infusing Intralipid into vessels using an electron microscope, was significantly decreased and the GBM exhibited little change in diabetic rats. In summary, the glomerular ESL may play a role in the pathogenesis of albuminuria in rats with early-stage diabetes.
Subject(s)
Diabetic Nephropathies/physiopathology , Endothelium, Vascular/physiopathology , Glomerular Filtration Barrier/physiopathology , Kidney Glomerulus/physiopathology , Albuminuria/etiology , Animals , Capillary Permeability , Diabetes Mellitus, Experimental/complications , Diabetic Nephropathies/blood , Diabetic Nephropathies/pathology , Diabetic Nephropathies/urine , Emulsions/administration & dosage , Endothelium, Vascular/metabolism , Endothelium, Vascular/ultrastructure , Extracellular Matrix/metabolism , Extracellular Matrix/ultrastructure , Glomerular Basement Membrane/metabolism , Glomerular Basement Membrane/physiopathology , Glomerular Basement Membrane/ultrastructure , Glomerular Filtration Barrier/metabolism , Glomerular Filtration Barrier/ultrastructure , Glomerular Mesangium/metabolism , Glomerular Mesangium/ultrastructure , Gold Colloid , Injections, Intravenous , Kidney Glomerulus/blood supply , Kidney Glomerulus/metabolism , Kidney Glomerulus/ultrastructure , Male , Phospholipids/administration & dosage , Rats , Rats, Sprague-Dawley , Serum Albumin , Soybean Oil/administration & dosage , Streptozocin , Vena Cava, InferiorABSTRACT
Hypertension is one of the major risk factors for chronic kidney disease. Using quantitative trait loci analysis, we identified the gene of the F-BAR protein NOSTRIN in the center of an overlapping region in rat and human quantitative trait loci that are associated with hypertension. Immunohistochemical analysis revealed a predominantly podocytic expression pattern of NOSTRIN in human and mouse glomeruli. Further, NOSTRIN colocalizes with cell-cell contact-associated proteins ß-catenin and zonula occludens-1 and interacts with the slit-membrane-associated adaptor protein CD2AP. In zebrafish larvae, knockdown of nostrin alters the glomerular filtration barrier function, inducing proteinuria and leading to ultrastructural morphological changes on the endothelial and epithelial side and of the glomerular basement membrane of the glomerular capillary loop. We conclude that NOSTRIN expression is an important factor for the integrity of the glomerular filtration barrier. Disease-related alteration of NOSTRIN expression may not only affect the vascular endothelium and, therefore, contribute to endothelial cell dysfunction but might also contribute to the development of podocyte disease and proteinuria.
Subject(s)
Adaptor Proteins, Signal Transducing/genetics , Glomerular Basement Membrane/physiopathology , Hypertension/genetics , Kidney Glomerulus/physiopathology , Membrane Proteins/genetics , Adaptor Proteins, Signal Transducing/metabolism , Animals , Glomerular Basement Membrane/metabolism , Glomerular Basement Membrane/ultrastructure , Hypertension/metabolism , Hypertension/physiopathology , Kidney Glomerulus/metabolism , Kidney Glomerulus/ultrastructure , Membrane Proteins/metabolism , Podocytes/metabolism , Proteinuria/genetics , Proteinuria/metabolism , Proteinuria/physiopathology , ZebrafishABSTRACT
Alport syndrome, hereditary glomerulonephritis with hearing loss, results from mutations in type IV collagen COL4A3, COL4A4, or COL4A5 genes. The mechanism for delayed glomerular disease onset is unknown. Comparative analysis of Alport mice and CD151 knockout mice revealed progressive accumulation of laminin 211 in the glomerular basement membrane. We show mesangial processes invading the capillary loops of both models as well as in human Alport glomeruli, as the likely source of this laminin. L-NAME salt-induced hypertension accelerated mesangial cell process invasion. Cultured mesangial cells showed reduced migratory potential when treated with either integrin-linked kinase inhibitor or Rac1 inhibitor, or by deletion of integrin α1. Treatment of Alport mice with Rac1 inhibitor or deletion of integrin α1 reduced mesangial cell process invasion of the glomerular capillary tuft. Laminin α2-deficient Alport mice show reduced mesangial process invasion, and cultured laminin α2-null cells showed reduced migratory potential, indicating a functional role for mesangial laminins in progression of Alport glomerular pathogenesis. Collectively, these findings predict a role for biomechanical insult in the induction of integrin α1ß1-dependent Rac1-mediated mesangial cell process invasion of the glomerular capillary tuft as an initiation mechanism of Alport glomerular pathology.
Subject(s)
Capillaries/pathology , Glomerular Mesangium/blood supply , Glomerular Mesangium/pathology , Integrin alpha1beta1/metabolism , Nephritis, Hereditary/metabolism , Nephritis, Hereditary/pathology , rac1 GTP-Binding Protein/antagonists & inhibitors , Actin Cytoskeleton/drug effects , Actin Cytoskeleton/metabolism , Animals , Biomechanical Phenomena/drug effects , Capillaries/drug effects , Capillaries/metabolism , Capillaries/physiopathology , Cell Movement/drug effects , Cells, Cultured , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Gene Deletion , Glomerular Basement Membrane/metabolism , Glomerular Basement Membrane/pathology , Glomerular Basement Membrane/physiopathology , Glomerular Basement Membrane/ultrastructure , Glomerular Mesangium/physiopathology , Glomerular Mesangium/ultrastructure , Humans , Hypertension/complications , Hypertension/metabolism , Hypertension/pathology , Hypertension/physiopathology , Laminin/metabolism , Mice , Mice, Knockout , Nephritis, Hereditary/complications , Nephritis, Hereditary/physiopathology , Protein Transport/drug effects , cdc42 GTP-Binding Protein/metabolism , rac1 GTP-Binding Protein/metabolismABSTRACT
Diabetic nephropathy, by far, is the most common cause of end stage renal disease in the US and many other countries. In type 1 diabetes, the natural history of diabetic nephropathy is tightly linked to evolution of classic lesions of the disease, namely glomerular basement membrane thickening, increased mesangial matrix, and reduced glomerular filtration surface density. These lesions progress in parallel and correlate with increased albumin excretion rate and reduced glomerular filtration rate across a wide range of renal function. In fact, the vast majority of the variances of albumin excretion and glomerular filtration rates can be explained by these glomerular lesions alone in type 1 diabetic patients. Although, classic lesions of diabetic nephropathy, indistinguishable from those of type 1 diabetes, also occur in type 2 diabetes, renal lesions are more heterogeneous in type 2 diabetic patients with some patients developing more advanced vascular or chronic tubulointerstitial lesions than diabetic glomerulopathy. More research biopsy longitudinal studies, especially in type 2 diabetic patients, are needed to better understand various pathways of renal injury in diabetic nephropathy.
Subject(s)
Diabetic Nephropathies/pathology , Disease Progression , Animals , Diabetes Mellitus, Type 2/pathology , Diabetes Mellitus, Type 2/physiopathology , Diabetic Nephropathies/physiopathology , Glomerular Basement Membrane/pathology , Glomerular Basement Membrane/physiopathology , Glomerular Basement Membrane/ultrastructure , Glomerular Filtration Rate , Humans , Time FactorsABSTRACT
BACKGROUND AND OBJECTIVES: X-linked Alport syndrome (X-AS) is caused by mutations of the COL4A5 gene, which encodes for the collagen IV α5 chain (α5[COLIV]), resulting in structural and functional abnormalities of the glomerular basement membrane (GBM) and leading to CKD. The aim of the present study was to evaluate the prognostic value of residual collagen IV chain expression in the GBM of patients with X-AS. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The medical records of 22 patients with X-AS from 21 unrelated families collected between 1987 and 2009 were reviewed (median age at last follow-up, 19.9 years; range, 5.4-35.1 years); GBM expression of α1, α3, and α5(COLIV) chains was assessed by immunofluorescence microscopy. RESULTS: GBM distribution of the α5(COLIV) chain was diffuse in 1 and segmental or absent in 21 of the 22 patients; the expression of the α3(COLIV) chain was diffuse in 5 of 22 patients and segmental or absent in 17 of 22 patients. Patients with diffuse staining for the α3(COLIV) chain presented with proteinuria significantly later (median age, 16.9 versus 6.1 years; P=0.02) and reached an estimated GFR < 90 ml/min per 1.73 m(2) at an older age (median age, 27.0 versus 14.9 years; P=0.01) compared with patients with segmental or absent staining. Two thirds of patients with abnormal α3(COLIV) expression by immunofluorescence studies had null or truncating COL4A5 mutations, as opposed to none of the 4 tested patients with diffuse α3(COLIV) chain glomerular distribution. CONCLUSIONS: These results indicate that maintained expression of the α3(COLIV) chain is an early positive prognostic marker in patients with X-linked Alport symdrome.
Subject(s)
Autoantigens/analysis , Collagen Type IV/analysis , Fluorescent Antibody Technique , Glomerular Basement Membrane/chemistry , Nephritis, Hereditary/metabolism , Adolescent , Adult , Age Factors , Biomarkers/analysis , Biopsy , Child , Child, Preschool , Disease Progression , Glomerular Basement Membrane/pathology , Glomerular Basement Membrane/physiopathology , Glomerular Filtration Rate , Humans , Infant , Kaplan-Meier Estimate , Male , Microscopy, Fluorescence , Nephritis, Hereditary/genetics , Nephritis, Hereditary/pathology , Nephritis, Hereditary/physiopathology , Predictive Value of Tests , Prognosis , Proteinuria/genetics , Proteinuria/metabolism , Retrospective Studies , Time Factors , Young AdultABSTRACT
BACKGROUND: We previously demonstrated that cellular and extracellular components of the blood-urine barrier in renal glomeruli are susceptible to damage in OVE transgenic mice, a valuable model of human diabetic nephropathy that expresses profound albuminuria. METHODS: To test our hypothesis that glomerular filtration barrier damage in OVE mice may be the result of oxidative insult to podocytes, 150-day-old bi-transgenic OVENmt diabetic mice that overexpress the antioxidant metallothionein specifically in podocytes were examined by enzyme-linked immunosorbent assay for albuminuria mitigation and by unbiased transmission electron microscopy (TEM) stereometry for protection from chronic structural diabetic complications. RESULTS: Although blood glucose and HbA(1c) levels were indistinguishable in OVE and OVENmt animals, albuminuria was significantly reduced (average >7-fold) in OVENmt mice through 8 months of age. Interestingly, the Nmt transgene provided significant glomerular protection against diabetic nephropathic complications outside of the podocyte. Glomerular filtration barrier damage was reduced in OVENmt mice, including significantly increased area occupied by endothelial luminal fenestrations (~13%), significantly reduced glomerular basement membrane (GBM) thickening (~17%) and significantly less podocyte effacement (~18%). In addition, OVENmt mice exhibited significantly reduced glomerular volume (~50%), fewer glomerular endothelial cells (~33%), fewer mesangial cells (~57%) and fewer total glomerular cells (~40%). CONCLUSIONS: These results provide evidence of oxidative damage to podocytes induces primary diabetic nephropathic features including severe and sustained albuminuria, specific glomerular filtration barrier damage and alterations in glomerular endothelial and mesangial cell number. Importantly, these diabetic complications are significantly mitigated by podocyte targeted metallothionein overexpression.
Subject(s)
Albuminuria/prevention & control , Diabetic Nephropathies/prevention & control , Glomerular Filtration Barrier/pathology , Metallothionein/biosynthesis , Podocytes/metabolism , Animals , Diabetic Nephropathies/physiopathology , Glomerular Basement Membrane/physiopathology , Glomerular Filtration Barrier/physiopathology , Kidney Glomerulus/pathology , Kidney Glomerulus/physiopathology , Metallothionein/genetics , Mice , Mice, Transgenic , Microscopy, Electron, Transmission , Podocytes/pathologyABSTRACT
Glomerular hypertension (ie, increased glomerular capillary pressure), has been shown to cause podocyte damage progressing to glomerulosclerosis in animal models. Increased glomerular capillary pressure results in an increase in wall tension that acts primarily as circumferential tensile stress on the capillary wall. The elastic properties of the glomerular basement membrane (GBM) and the elastic as well as contractile properties of the cytoskeleton of the endothelium and of podocyte foot processes resist circumferential tensile stress. Whether the contractile forces generated by podocytes are able to equal circumferential tensile stress to effectively counteract wall tension is an open question. Mechanical stress is transmitted from the GBM to the actin cytoskeleton of podocyte foot processes via cell-matrix contacts that contain mainly integrin α3ß1 and a variety of linker, scaffolding, and signaling proteins, which are not well characterized in podocytes. We know from in vitro studies that podocytes are sensitive to stretch, however, the crucial mechanosensor in podocytes remains unclear. On the other hand, in vitro studies have shown that in stretched podocytes specific signaling cascades are activated, the synthesis and secretion of various hormones and their receptors are increased, cell-cycle arrest is reinforced, cell adhesion is altered through secretion of matricellular proteins and changes in integrin expression, and the actin cytoskeleton is reorganized in a way that stress fibers are lost. In summary, current evidence suggests that in glomerular hypertension podocytes primarily aim to maintain the delicate architecture of interdigitating foot processes in the face of an expanding GBM area.
Subject(s)
Actin Cytoskeleton/physiology , Adaptation, Physiological , Glomerular Basement Membrane/physiopathology , Hypertension, Renal/physiopathology , Podocytes/physiology , Animals , Blood Pressure , Cell Adhesion Molecules/physiology , Elasticity , Humans , Signal Transduction , Stress, MechanicalABSTRACT
Podocytes of the kidney adhere tightly to the underlying glomerular basement membrane (GBM) in order to maintain a functional filtration barrier. The clinical importance of podocyte binding to the GBM via an integrin-laminin-actin axis has been illustrated in models with altered function of α3ß1 integrin, integrin-linked kinase, laminin-521, and α-actinin 4. Here we expanded on the podocyte-GBM binding model by showing that the main podocyte adhesion receptor, integrin α3ß1, interacts with the tetraspanin CD151 in situ in humans. Deletion of Cd151 in mouse glomerular epithelial cells led to reduced adhesive strength to laminin by redistributing α3ß1 at the cell-matrix interface. Moreover, in vivo podocyte-specific deletion of Cd151 led to glomerular nephropathy. Although global Cd151-null B6 mice were not susceptible to renal disease, as has been shown previously, increasing blood and transcapillary filtration pressure induced nephropathy in these mice. Importantly, blocking the angiotensin-converting enzyme in renal disease-susceptible global Cd151-null FVB mice prolonged their median life span. Together, these results establish CD151 as a crucial modifier of integrin-mediated adhesion of podocytes to the GBM and show that blood pressure is an important factor in the initiation and progression of Cd151 knockout-induced nephropathy.
Subject(s)
Blood Pressure/physiology , Kidney Failure, Chronic/physiopathology , Tetraspanin 24/deficiency , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Animals , Cell Adhesion/drug effects , Cell Adhesion/physiology , Epithelial Cells/pathology , Epithelial Cells/physiology , Glomerular Basement Membrane/pathology , Glomerular Basement Membrane/physiopathology , Humans , Integrin alpha3beta1/physiology , Kidney Failure, Chronic/drug therapy , Kidney Failure, Chronic/pathology , Mice , Mice, 129 Strain , Mice, Inbred C57BL , Mice, Knockout , Podocytes/pathology , Podocytes/physiology , Renin-Angiotensin System/drug effects , Renin-Angiotensin System/physiology , Tetraspanin 24/genetics , Tetraspanin 24/metabolismABSTRACT
Animal models have provided important insights into human renal diseases that arise from mutations in genes that encode or regulate the synthesis of glomerular basement membrane proteins. This chapter describes several well-characterized animal models of type IV collagen disorders (Alport syndrome, HANAC syndrome), a laminin disorder (Pierson syndrome), nail-patella syndrome and HERNS syndrome. These models can be exploited in studies of the pathogenesis and treatment of such disorders.
Subject(s)
Disease Models, Animal , Glomerular Basement Membrane/physiopathology , Kidney Diseases/diagnosis , Kidney Diseases/etiology , Abnormalities, Multiple/diagnosis , Abnormalities, Multiple/etiology , Abnormalities, Multiple/physiopathology , Animals , Collagen Type IV/genetics , Collagen Type IV/metabolism , Dogs , Eye Abnormalities/diagnosis , Eye Abnormalities/etiology , Eye Abnormalities/physiopathology , Humans , Kidney Diseases/physiopathology , Laminin/genetics , Laminin/metabolism , Mice , Mutation/genetics , Myasthenic Syndromes, Congenital , Nail-Patella Syndrome/diagnosis , Nail-Patella Syndrome/etiology , Nail-Patella Syndrome/physiopathology , Nephritis, Hereditary/diagnosis , Nephritis, Hereditary/etiology , Nephritis, Hereditary/physiopathology , Nephrotic Syndrome , Pupil Disorders/diagnosis , Pupil Disorders/etiology , Pupil Disorders/physiopathologyABSTRACT
This review provides current information about glomerular disorders that arise directly from inherited abnormalities in extracellular matrix proteins intrinsic to the glomerular basement membrane (Alport syndrome, thin basement membrane nephropathy, HANAC syndrome and Pierson syndrome). The authors also discuss disorders involving genetic defects in cellular proteins that result in structural defects in glomerular basement membranes (MYH9-related disorders, nail-patella syndrome).
Subject(s)
Genetic Predisposition to Disease/genetics , Glomerular Basement Membrane/physiopathology , Kidney Diseases/genetics , Kidney/physiopathology , Animals , HumansABSTRACT
In patients with progressive podocyte diseases, such as focal segmental glomerulosclerosis and membranous nephropathy, there is enhanced expression of transforming growth factor (TGF-ß) in podocytes. Biomechanical strain in these diseases may cause overexpression of TGF-ß and angiotensin II (Ang II) by podocytes. Oxidative stress induced by Ang II may activate the latent TGF-ß. Increased TGF-ß activity by podocytes may induce not only the thickening of the glomerular basement membrane (GBM), but also podocyte apoptosis and/or detachment from the GBM, initiating the development of glomerulosclerosis. Furthermore, mesangial matrix expansion frequently occurs in podocyte diseases in association with the development of glomerulosclerosis. This review examines open questions on the pathogenic role of TGF-ß that links podocyte injury to GBM thickening, podocyte loss, mesangial matrix expansion and glomerulosclerosis in podocyte diseases. It also describes paracrine regulatory mechanisms of podocyte TGF-ß on mesangial cells leading to increased matrix synthesis.